PURPOSE
Although considerable progress has been made in the treatment of acute myeloid leukemia (AML), therapeutic outcomes remain unsatisfactory. Thus, it is of great important to investigate the leukemiagenesis mechanism of AML. Previous studies indicated that Calsyntenin-2 (CLSTN2) was closely associated with the pr...
Yu-Ting Dou, Xu Cao, Ke Ji et al.· Cellular Signalling· 0 citations
Repeat infusion of chimeric antigen receptor (CAR) T-cell is effective for patients with refractory or relapsed multiple myeloma (RRMM) after failing a prior CAR Tcell therapy. It is unknown whether B-cell maturation antigen (BCMA) CAR T-cell is effective for patients with RRMM after anti-G protein-coupled receptor, cl...
Xiao-Tian Zhang, Fan Xia, Kun-Ming Qi et al.· Haematologica· 0 citations
BACKGROUND
The MLL-rearranged (MLL-r) acute myeloid leukemia (AML) represents a hematological malignancy with a dismal prognosis and a pressing demand for innovative therapeutic targets. CAPN1 is overexpressed in MLL-r AML and predicts poor prognosis, however, its roles in MLL-r AML remains unclear.
METHODS
Prognosti...
Jia-Yi Liu, Xu Cao, Yan Lu et al.· Biochimica et Biophysica Act...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.